Insider Transactions in Q2 2024 at Medtronic PLC (MDT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2024
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
19,113
-5.94%
|
$1,586,379
$83.79 P/Share
|
|
Jun 07
2024
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,113
+5.4%
|
$1,185,006
$62.76 P/Share
|
|
May 01
2024
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.42%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Kevin E Lofton Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-2.99%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.21%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.25%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.42%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.5%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.97%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Lidia Fonseca Director |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-4.21%
|
$12,960
$80.89 P/Share
|
|
May 01
2024
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-2.26%
|
$15,360
$80.89 P/Share
|
|
Apr 29
2024
|
Gregory P Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,821
+50.0%
|
$145,680
$80.86 P/Share
|
|
Apr 29
2024
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+25.21%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+12.01%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+2.73%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+4.49%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+5.33%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+9.86%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Lidia Fonseca Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+36.03%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+20.3%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+4.56%
|
$173,200
$80.86 P/Share
|
|
Apr 08
2024
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Open market or private sale
|
Direct |
854
-2.97%
|
$70,882
$83.14 P/Share
|